BOM/524404 (BOM/524404)

Bombay Stock Exchange: BOM/524404 · INR

₹305

+5.30 (+1.8%)· Recorded snapshot

Market cap	138.3B
Revenue (ttm)	31.7B
Net income (ttm)	5.2B
EPS (ttm)	₹11.4
P/E (trailing)	26.8x
P/E (forward)	23.6x
Dividend	₹0.90 (0.29%)
Volume	56,704

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 31.7B
Net income (ttm): 5.2B
EPS (ttm): ₹11.4
P/E (trailing): 26.8x
P/E (forward): 23.6x
Market cap: 138.3B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E23.6

P25 n/aP50 n/aP75 n/a

Trailing P/E26.8

P25 n/aP50 n/aP75 n/a

ROE15.2

P25 n/aP50 n/aP75 n/a

ROIC19.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BOM/524404 indicators

Market & fundamental data

Available fields

249

Groups with data

Currency

INR

Showing 249 of 249 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	INR
Country	India
Country code	IN
Earnings date	2026-11-04
Employees	1,685
Employees change	-155
Employees growth	-8.42%
Enterprise value	INR 132.1B
Exchange	Bombay Stock Exchange
Financial currency	INR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	March
Founded	1992
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	INE750C01026
Last earnings date	2026-08-12
Last refreshed	2026-10-28
Last stock split date	2008-03-11
Last stock split type	Forward
Market cap	INR 138.3B
Next earnings date	2026-11-04
Price	INR 305.20
Price currency	INR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	bom/524404
Website	https://marksanspharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	33.79x
Average P/E ratio (3Y)	25.34x
Average P/E ratio (5Y)	19.65x
Earnings yield	3.73%
EV/Earnings	25.57x
EV/EBIT	21.53x
EV/EBITDA	18.52x
EV/FCF	40.33x
EV/Sales	4.17x
FCF / EV yield	2.48%
FCF yield	2.37%
Forward P/E	23.56x
Graham number	129.18406
Graham upside	-56.92%
Industry forward P/E	32.11x
Industry P/E	38.96x
Lynch fair value	INR 173.30
Lynch upside	-42.21%
P/(FCF - SBC) ratio	42.65x
P/(OCF - SBC) ratio	30.41x
P/B ratio	4.53x
P/E ratio	26.78x
P/FCF ratio	42.22x
P/OCF ratio	30.19x
P/S ratio	4.36x
Price / tangible book value	4.83x
Price/EBITDA ratio	20.42x
Sector forward P/E	36.13x
Sector P/E	45.65x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	19.35%
EBITDA margin	21.35%
Effective tax rate	24.51%
FCF margin	11.1%
Gross margin	55.25%
Operating margin	19.35%
Pretax margin	21.77%
Profit margin	16.29%
Profit per employee	INR 3.1M
Profitable quarters	33
Profitable years	14
Revenue per employee	INR 18.8M
ROA	8.85%
ROA (5Y)	9.38%
ROCE	15.08%
ROE	15.16%
ROE (5Y)	16.71%
ROIC	19.26%
ROIC (5Y)	19.02%
SBC / revenue	0.11%
Tax / revenue	5.34%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	47.24%
EPS growth (Q)	168.99%
EPS growth (QoQ)	6.18%
EPS growth 10Y	24.98%
EPS growth 3Y	20.97%
EPS growth 5Y	13.43%
EPS growth quarters	4
EPS growth years	4
FCF growth	870.81%
FCF growth 3Y	21.25%
FCF growth 5Y	19.91%
Gross profit growth	20.5%
Gross profit growth (Q)	38.85%
Gross profit growth 3Y	22.62%
Gross profit growth 5Y	17.31%
Net income growth	47.58%
Net income growth (Q)	169.51%
Net income growth (QoQ)	6.1%
Net income growth 3Y	23.51%
Net income growth 5Y	15.47%
Net income growth quarters	4
Net income growth years	4
OCF growth	121.68%
OCF growth 10Y	30.99%
OCF growth 3Y	24.5%
OCF growth 5Y	20.73%
Operating income growth	48.13%
Operating income growth (Q)	144.31%
Operating income growth 3Y	24.99%
Operating income growth 5Y	13.7%
Revenue growth	19.59%
Revenue growth (Q)	35.62%
Revenue growth (QoQ)	-1.79%
Revenue growth 10Y	13.81%
Revenue growth 3Y	18.25%
Revenue growth 5Y	17.66%
Revenue growth quarters	21
Revenue growth years	9

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	INR -1.3B
Depreciation and amortization	INR 634.6M
EBIT	INR 6.1B
EBITDA	INR 6.8B
EPS	INR 11.40
Financing cash flow	INR -709.3M
Free cash flow	INR 3.3B
Free cash flow minus SBC	INR 3.2B
Gross profit	INR 17.5B
Income taxes	INR 1.7B
Investing cash flow	INR -2.5B
Net borrowing	INR -318.9M
Net cash flow	INR 1.4B
Net income	INR 5.2B
Operating cash flow minus SBC	INR 4.5B
Operating income	INR 6.1B
Revenue	INR 31.7B
Stock-based compensation	INR 33.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	INR 66.71
Debt / EBITDA	0.48
Debt / equity	0.11
Debt / FCF	1.05
Interest coverage	25.44
Net cash (debt)	INR 6.5B
Net cash / market cap	4.68%
Net cash growth	68.59%
Net debt / EBITDA	-0.96
Net debt / equity	-0.21
Net debt / FCF	-1.98
Piotroski F-Score	5
Shareholders' equity	INR 30.5B
Tangible book value	INR 28.6B
Tangible book value per share	INR 63.14
Total cash	INR 9.9B
Total debt	INR 3.4B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.83
Current ratio	5.17
Inventory turnover	1.47
Quick ratio	3.13
Working capital	INR 22B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.22%
Dividend growth	12.5%
Dividend growth (10Y)	22.32%
Dividend growth (3Y)	21.64%
Dividend growth (5Y)	29.2%
Dividend growth years	3
Dividend payment date	2026-09-26
Dividend payment years	13
Dividend payout frequency	Annual
Dividend per share	INR 0.90
Dividend yield	0.29%
Ex-dividend date	2026-08-20
Last dividend	INR 0.90
Payout ratio	7.9%
Shareholder yield	0.08%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	486.89%
10Y return CAGR	19.72%
10Y total return	504.85%
150-day SMA	INR 259.18
15Y price change	13,720.28%
15Y return CAGR	39.23%
15Y total return	14,218.1%
1D price change	1.77%
1M price change	-10.98%
1M total return	-10.98%
1W price change	0.82%
1W total return	0.82%
1Y price change	69.53%
1Y return CAGR	70.06%
1Y total return	70%
20-day SMA	INR 313.23
200-day SMA	INR 237.90
20Y price change	2,712%
20Y return CAGR	18.36%
20Y total return	2,813.3%
3M price change	21.79%
3M total return	22.12%
3Y price change	185.76%
3Y return CAGR	42.29%
3Y total return	188.14%
50-day SMA	INR 322.22
50-day SMA vs 200-day SMA	50over200
52-week high	INR 350.75
52-week high date	2026-09-24
52-week low	INR 156.00
52-week low date	2026-03-30
5Y price change	355.08%
5Y return CAGR	35.91%
5Y total return	363.7%
6M price change	57.64%
6M total return	58.07%
All-time high	INR 358.50
All-time high date	2024-12-02
All-time low	INR 1.27
All-time low date	2012-05-18
Average true range (ATR)	INR 11.79
Average volume	106.6K
Change from 52-week high	-12.99%
Change from 52-week low	95.64%
Change from all-time high	-16.35%
Change from all-time low	23,514.17%
Change from open	0.99%
Day's gap	0.77%
Dollar volume	INR 17.3M
High price	INR 308.40
Low price	INR 299.00
Monthly RSI	62.28
Open price	INR 302.20
Position in 52-week range	65.96%
Previous close	INR 299.90
Price vs 150-day SMA	15.71%
Price vs 20-day SMA	-4.25%
Price vs 200-day SMA	26.06%
Price vs 50-day SMA	-6.93%
Relative volume	0.53
RSI	42.81
Sharpe ratio	1.34
Sharpe ratio (3Y)	0.88
Sharpe ratio (5Y)	0.8
Sortino ratio	2.64
Sortino ratio (3Y)	1.6
Sortino ratio (5Y)	1.47
Volume	56.7K
Weekly RSI	57.25
YTD price change	66.47%
YTD total return	66.93%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	214.4M
Shares change (QoQ)	-0.01%
Shares change (YoY)	0.22%
Shares held by insiders	43.87%
Shares held by institutions	12.66%

Deeper analysis on BOM/524404

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BOM/524404 report

Is a complete BOM/524404 research report available?

No complete published report is available for bom/524404 (BOM/524404) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BOM/524404 (BOM/524404)

Price

Financial snapshot

Fair-value bridge

Latest news · BOM/524404

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BOM/524404 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BOM/524404

Frequently asked questions